Speaker illustration

Doctor Toru Oka

Osaka International Cancer Institute, Osaka (Japan)

Member of:

European Society of Cardiology

Pathological assessment of osimertinib-associated cardiotoxicity in EGFR-mutated non-small cell lung cancer patients

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk